Applications published 14 February 2007

Capsules derived from asymmetric production
Bioprogress Technology 1750646*

Pharmaceutical tablets having a separation mark positioned on the side of said tablets
Accu-Break Pharmaceuticals 1750647*

Dental cement with grafted poly-acid composite particles
Dentsply Detrey 1750648*

Glass compsns as an antimicrobial additive for dental materials
Schott 1750649*

Use of nanoparticles to adjust the refractive index of dental compsns
3M Innovative Properties 1750650*

Use of heat shock protein inhibitors for the reduction of hair growth
The Gillette Company 1750653*

Intravitreal implants in conjunction with photodynamic therapy to improve vision
Allergan 1750664*

Biodegradable intravitreal tyrosine kinase inhibitors implants
Allergan 1750665*

Methods and articles for the delivery for the delivery of therapeutic agents
Agency for Science, Technology and Research 1750666*

Aerosolised fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
Corus Pharma 1750667*

Liquids containing suspended glass particles
Cambridge Biostability 1750668*

Solid pharmaceutical form comprising an LTB4 antagonist
Boehringer Ingelheim International 1750669*

Buccal, polar and non-polar sprays containing propofol
Novadel Pharma 1750670*

Liposomal assembly for therapeutic and/or diagnostic use
Bracco Research 1750671*

Encapsulated transfer factor compsns and methods of use
Ramaekers, Jospeh 1750672*

Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
Inex Pharmaceuticals 1750673*

Microparticles for oral delivery
Advanced Bionutrition 1750674*

Stable oral pharmaceutical compsns of buprenorphine and derivatives
Galephar 1750675*

Ingestible device platform for the colon
Spectrum Dynamics 1750676*

Oral therapeutic compound delivery system
Imaginot 1750677*

Dosage form for delivery of multiple drug delivery forms
Alza 1750678*

Gel compsn comprising charged polymers
Universiteit Utrecht Holding 1750679*

Controlled release press-coated formulations of water-soluble active agents
Alpharma 1750680*

Decontaminant edible product, methods of production and uses thereof
De Novo 1750681*

Nutritional formulations
Drugtech 1750682*

Sustained release formulations
Amgen 1750683*

Dermal system of two patches detachably secured to each other for providing therapy to an area of the body
Kimberley-Clark Worldwide 1750684*

Treatment of apoptosis
Ketocytonix 1750686*

Indole and azaindole derivatives with antitumour action
Nikem Research 1750687*

Steroid intraocular implants having an extended sustained release for a period of greater than two months
Allergan 1750688*

Treating seizures using ice inhibitors
Vertex Pharmaceuticals 1750689*

Use of targeted oxidative therapeutic formulation in treatment of cancer
Hofmann, Robert 1750690*

Compounds for treatment of AIDS and other diseases
New Era Biotech 1750691*

Method of tonic treatment with oxyphenbutazone derivatives
A-Viral; Goddard, Christopher 1750692*

Oculoselective drugs and prodrugs
Othera Pharmaceuticals 1750693*

Metabolites of selective androgen receptor modulators and methods of use thereof
University of Tennessee Research Foundation 1750694*

Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight
Laboratoires Expanscience 1750695*

Resistance-repellant retroviral protease inhibitors
Sequoia Pharmaceuticals 1750696*

Methods and compsns using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
Celgene 1750697*

5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
Bayer Pharmaceuticals 1750698*

Treatment of diet-related conditions using phospholipase-A2 inhibitors comprising indoles and related compounds
Ilypsa 1750699*

Liquid preparation for veterinary medicine, method for the production thereof, and use of the same
Boehringer Ingelheim Vetmedica 1750700*

Amorphous clopidogrel hydrochloride and its antithrombitic use
Ivax Pharmaceuticals 1750701*

Method of bowel cleansing
Braintree Laboratories 1750702*

Method for reducing gastrointestinal toxicity due to the administration of tegafur
Taiho Pharmaceutical 1750703*

Urea antagonists of P2Y1 receptor useful in the treatment of thrombitic conditions
Bristol-Myers Squibb 1750704*

Selective serotonin receptor inverse agonists as therapeutics for disease
Acadia Pharmaceuticals 1750705*

Dual small molecule inhibitors of cancer and angiogenesis
University of Virginia Patent Foundation 1750706*